Rosenthal, E. L., Moore, L. S., Tipirneni, K., de Boer, E., Stevens, T. M., Hartman, Y. E., . . . Warram, J. M. (2017). Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer. Clin Cancer Res.

Rosenthal, Eben L., Lindsay S. Moore, Kiranya Tipirneni, Esther de Boer, Todd M. Stevens, Yolanda E. Hartman, William R. Carroll, Kurt R. Zinn, and Jason M. Warram. "Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer." Clin Cancer Res 2017.

Rosenthal, Eben L., et al. "Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer." Clin Cancer Res 2017.